Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical Carcinoma
- 1 November 1998
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 71 (2), 270-277
- https://doi.org/10.1006/gyno.1998.5163
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hypoxia-specific cytotoxins in cancer therapySeminars in Radiation Oncology, 1996
- Tumor hypoxia and heterogeneity: Challenges and opportunities for the futureSeminars in Radiation Oncology, 1996
- Measuring tumor hypoxiaSeminars in Radiation Oncology, 1996
- Hypoxia and radiation response in human tumorsSeminars in Radiation Oncology, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroidsInternational Journal of Cancer, 1995
- Analysis of the Effects of Oxygen Supply and Demand on Hypoxic Fraction in TumorsActa Oncologica, 1995
- ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.Environmental Health Perspectives, 1993
- Comparison of Proliferating Cell Nuclear Antigen to Tritiated Thymidine As a Marker of Proliferating Hepatocytes in RatsEnvironmental Health Perspectives, 1993